Is genome sequencing the catalyst for diagnostics or the rate-limiting step?
GEOFF DAVISON | Chief Executive Officer | Bionow
PAUL JONES | Global Head of Population Genomics | Illumina
TONU ESKO | Professor of Human Genomics at Institute of Genomics | University of Tartu
JO MASON | R&D Director | Yourgene Health
SAMANTHA BRAMLEY | Director of Market Access & Reimbursement | Roche Sequencing Solutions